NASDAQ:ARTL

Artelo Biosciences Stock Insider Trading

etoro logo Buy ARTL
*Your capital is at risk
$1.45
+0.0200 (+1.40%)
At Close: Jun 02, 2026

Artelo Biosciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 883.78K and sold 591.24K ARTL shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
100.00
Buy 883.78K shares
Sell 591.24K shares
65% Buy Activity
Weak Positive Correlation

No Significant Signals

No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date Type Person Role Amount
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 55 634
Value: $86.2K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 38 340
Value: $59.4K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 5 000
Value: $8K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 85 000
Value: $267.8K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 55 634
Value: $2.22M
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 5 000
Value: $149.3K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 38 340
Value: $874.2K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Gorgas Gregory D.
Pres, CEO, CFO, Treas & Sec
CEO / President 90 334
Value: $853.7K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Reyes Gregory
Director
Director 8 000
Value: $12.4K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Reyes Gregory
Director
Director 1 083
Value: $2K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Reyes Gregory
Director
Director 667
Value: $1K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Reyes Gregory
Director
Director 667
Value: $1K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Reyes Gregory
Director
Director 1 083
Value: $2K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Matsui Connie
Director
Director 667
Value: $1K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Matsui Connie
Director
Director 1 767
Value: $3K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Blayney Douglas
Director
Director 1 200
Value: $2K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Blayney Douglas
Director
Director 1 083
Value: $2K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Blayney Douglas
Director
Director 667
Value: $1K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Blayney Douglas
Director
Director 9 300
Value: $371.1K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Blayney Douglas
Director
Director 1 200
Value: $35.8K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Blayney Douglas
Director
Director 667
Value: $10.0K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Blayney Douglas
Director
Director 667
Value: $3K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Blayney Douglas
Director
Director 667
Value: $1K
Feb 28, 2024
Sell
Stock Option (right to buy)
D-Return
Blayney Douglas
Director
Director 1 083
Value: $2K
Feb 28, 2024
Buy
Stock Option (right to buy)
A-Award
Matsui Connie
Director
Director 10 634
Value: $16.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT ARTELO BIOSCIENCES, INC.
Artelo Biosciences
Artelo Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on developing and commercializing treatments to modulate the endocannabinoid system. Its product candidate pipeline includes ART27.13, a synthetic G protein-coupled receptor agonist, which is in Phase 1b/2a clinical trial for the treatment of anorexia associated with cancer; ART12.11, a synthetic cannabidiol cocrystal for the treatment of inflammatory bowel disease and ...
GOLDEN STAR
Ticker Change Signal Date
RUN
$12.83
18.86% May 06
GLBE
$31.61
5.35% May 05
SAP
$172.39
10.69% May 05
W
WCLD
$27.34
27.18% Apr 29
ADBE
$243.57
7.61% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE